EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Beyond Insulin

Huajing Ni, Jennifer R Snaith, Jerry R Greenfield

Endocrinology and Metabolism Clinics of North America · 2026-09 · 55 (3) · 379-393

DOI: 10.1016/j.ecl.2026.04.001 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endocrinology and Metabolism Clinics of North America, 2026-09. Verfasst von Huajing Ni und 2 weiteren Autor:innen. Beteiligte Einrichtung: Translational Diabetes Lab, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia; St. Vincent's Healthcare Campus, School of C…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Insulin Resistance, Hypoglycemic Agents, Insulin. Die Arbeit nennt 92 Literaturangaben. Gefördert von: Australian Government, Breakthrough T1D Australia, Breakthrough T1D.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A century after the discovery of insulin, people with type 1 diabetes continue to experience elevated cardiovascular risk and associated mortality, incompletely explained by dysglycemia and traditional risk factors. There is increasing recognition of the contributions of glycemic variability, insulin-related weight gain, insulin resistance and other hormonal disturbances to this risk, necessitating additional agents targeting these pathways. This article explores these mechanisms and provides an overview of current available agents. Finally, we highlight the sparsity of data on long-term outcomes and hard cardiovascular endpoints.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Insulin ResistanceHypoglycemic AgentsInsulinCardiovascular DiseasesHumans

Stichwörter der Autor:innen

Adjunctive therapiesCardiometabolic riskGlycemic variabilityHormonal defectsInsulin resistanceType 1 diabetesWeight management

Substanzen

Hypoglycemic AgentsInsulin

Autor:innen und Institutionen

  • Translational Diabetes Lab, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia; St. Vincent's Healthcare Campus, School of Clinical Medicine, Faculty of Medicine and Health, University of New So…

Förderung

  • Australian Government
  • Breakthrough T1D Australia
  • Breakthrough T1D
  • Commonwealth Scientific and Industrial Research Organisation

Zitieren

APA

Ni, H., Snaith, J. R., & Greenfield, J. R. (2026). Beyond Insulin. Endocrinology and Metabolism Clinics of North America, 55(3), 379-393. https://doi.org/10.1016/j.ecl.2026.04.001

Vancouver

Ni H, Snaith JR, Greenfield JR. Beyond Insulin. Endocrinology and Metabolism Clinics of North America. 2026;55(3):379-393. doi:10.1016/j.ecl.2026.04.001

BibTeX
@article{Ni2026,
  author = {Ni, Huajing and Snaith, Jennifer R and Greenfield, Jerry R},
  title = {Beyond Insulin},
  journal = {Endocrinology and Metabolism Clinics of North America},
  year = {2026},
  volume = {55},
  number = {3},
  pages = {379--393},
  doi = {10.1016/j.ecl.2026.04.001}
}
Kostenlos starten →